201 related articles for article (PubMed ID: 17325219)
1. Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.
Novak KF; Diamond WJ; Kirakodu S; Peyyala R; Anderson KW; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2007 May; 51(5):1837-9. PubMed ID: 17325219
[TBL] [Abstract][Full Text] [Related]
2. The effect of lactoferrin on oral bacterial attachment.
Arslan SY; Leung KP; Wu CD
Oral Microbiol Immunol; 2009 Oct; 24(5):411-6. PubMed ID: 19702956
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
[TBL] [Abstract][Full Text] [Related]
4. Rice peptide with amino acid substitution inhibits biofilm formation by Porphyromonas gingivalis and Fusobacterium nucleatum.
Matsugishi A; Aoki-Nonaka Y; Yokoji-Takeuchi M; Yamada-Hara M; Mikami Y; Hayatsu M; Terao Y; Domon H; Taniguchi M; Takahashi N; Yamazaki K; Tabeta K
Arch Oral Biol; 2021 Jan; 121():104956. PubMed ID: 33157493
[TBL] [Abstract][Full Text] [Related]
5. SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.
Weistroffer PL; Joly S; Srikantha R; Tack BF; Brogden KA; Guthmiller JM
Oral Microbiol Immunol; 2008 Apr; 23(2):89-95. PubMed ID: 18279175
[TBL] [Abstract][Full Text] [Related]
6. Effects of Sodium Tripolyphosphate on Oral Commensal and Pathogenic Bacteria.
Moon JH; Noh MH; Jang EY; Yang SB; Kang SW; Kwack KH; Ryu JI; Lee JY
Pol J Microbiol; 2019; 68(2):263-268. PubMed ID: 31257792
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.
Sánchez MC; Ribeiro-Vidal H; Esteban-Fernández A; Bartolomé B; Figuero E; Moreno-Arribas MV; Sanz M; Herrera D
BMC Complement Altern Med; 2019 Jun; 19(1):145. PubMed ID: 31226983
[TBL] [Abstract][Full Text] [Related]
8. Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia by protegrins.
Miyasaki KT; Iofel R; Oren A; Huynh T; Lehrer RI
J Periodontal Res; 1998 Feb; 33(2):91-8. PubMed ID: 9553868
[TBL] [Abstract][Full Text] [Related]
9. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of povidone-iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum.
Hosaka Y; Saito A; Maeda R; Fukaya C; Morikawa S; Makino A; Ishihara K; Nakagawa T
Arch Oral Biol; 2012 Apr; 57(4):364-8. PubMed ID: 21958970
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens.
McLean DT; McCrudden MT; Linden GJ; Irwin CR; Conlon JM; Lundy FT
Regul Pept; 2014 Nov; 194-195():63-8. PubMed ID: 25447193
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial photodynamic therapy alone or in combination with antibiotic local administration against biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
Tavares LJ; de Avila ED; Klein MI; Panariello BHD; Spolidório DMP; Pavarina AC
J Photochem Photobiol B; 2018 Nov; 188():135-145. PubMed ID: 30267963
[TBL] [Abstract][Full Text] [Related]
14. Peptide-modified nanoparticles inhibit formation of
Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
[TBL] [Abstract][Full Text] [Related]
15. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model.
Sánchez MC; Marín MJ; Figuero E; Llama-Palacios A; León R; Blanc V; Herrera D; Sanz M
J Periodontal Res; 2014 Feb; 49(1):20-8. PubMed ID: 23581569
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of taurolidine gel on bacteria associated with periodontitis.
Eick S; Gloor N; Püls C; Zumbrunn J; Sculean A
Clin Oral Investig; 2016 Apr; 20(3):597-606. PubMed ID: 26254142
[TBL] [Abstract][Full Text] [Related]
17. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms.
Huang CB; Alimova Y; Myers TM; Ebersole JL
Arch Oral Biol; 2011 Jul; 56(7):650-4. PubMed ID: 21333271
[TBL] [Abstract][Full Text] [Related]
18. Combined antioxidant effects of Neem extract, bacteria, red blood cells and Lysozyme: possible relation to periodontal disease.
Heyman L; Houri-Haddad Y; Heyman SN; Ginsburg I; Gleitman Y; Feuerstein O
BMC Complement Altern Med; 2017 Aug; 17(1):399. PubMed ID: 28797303
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways.
Domon H; Hiyoshi T; Maekawa T; Yonezawa D; Tamura H; Kawabata S; Yanagihara K; Kimura O; Kunitomo E; Terao Y
Microbiol Immunol; 2019 Jun; 63(6):213-222. PubMed ID: 31106894
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens.
Yang LC; Hu SW; Yan M; Yang JJ; Tsou SH; Lin YY
J Periodontol; 2015 Feb; 86(2):310-8. PubMed ID: 25345340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
